Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 32007R0108

Commission Regulation (EC) No 108/2007 of 5 February 2007 amending Regulation (EC) No 1356/2004 as regards the conditions for authorisation of the feed additive Elancoban, belonging to the group of coccidiostats and other medicinal substances (Text with EEA relevance )

OJ L 31, 6.2.2007, p. 4–5 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, RO, SK, SL, FI, SV)
OJ L 56M, 29.2.2008, p. 22–23 (MT)
Special edition in Croatian: Chapter 03 Volume 033 P. 246 - 247

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg/2007/108/oj

Date of document:
05/02/2007
Date of effect:
26/02/2007; Entry into force Date pub. + 20 See Art 2
Date of end of validity:
No end date
Author:
European Commission
Form:
Regulation
Additional information:
Extended to the EEA by 22007D0074, EEA relevance
Authentic language:
Bulgarian, Spanish, Czech, Danish, German, Estonian, Greek, English, French, Italian, Latvian, Lithuanian, Hungarian, Maltese, Dutch, Polish, Portuguese, Romanian, Slovak, Slovenian, Finnish, Swedish, Icelandic, Norwegian
Treaty:
Treaty establishing the European Community
Legal basis:
Link
Link
Link
Select all documents mentioning this document
Modifies:
Relation Act Comment Subdivision concerned From To
Modifies 32004R1356 Replacement annex 1 26/02/2007
Modified by:
Relation Act Comment Subdivision concerned From To
Corrected by 32007R0108R(01) (DE)
Instruments cited:
Link
Link

6.2.2007   

EN

Official Journal of the European Union

L 31/4

COMMISSION REGULATION (EC) No 108/2007

of 5 February 2007

amending Regulation (EC) No 1356/2004 as regards the conditions for authorisation of the feed additive Elancoban, belonging to the group of coccidiostats and other medicinal substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition (1) and in particular Article 13(3) thereof,

Whereas:

(1)

The additive monensin sodium (Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200) was authorised under certain conditions in accordance with Council Directive 70/524/EEC (2). Commission Regulation (EC) No 1356/2004 (3) authorised that additive for 10 years for use for chickens for fattening, chickens reared for laying and turkeys, linking the authorisation to the person responsible for putting that additive into circulation. That additive was notified as an existing product on the basis of Article 10 of Regulation (EC) No 1831/2003. Since all the information required under that provision was submitted, that additive was entered into the Community Register of Feed Additives.

(2)

Regulation (EC) No 1831/2003 provides for the possibility of modifying the authorisation of an additive further to a request from the authorisation holder and an opinion of the European Food Safety Authority (the Authority). The holder of the authorisation of the additive monensin sodium (Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200) has submitted an application which proposes changing the terms of the authorisation by introducing maximum residue limits (MRLs) as evaluated by the Authority.

(3)

In its opinion adopted on 21 November 2006, the Authority proposed to establish provisional MRLs for the active substance concerned (4). It may be necessary to review the MRLs set out in the Annex in the light of the results of a future evaluation of that active substance by the European Medicines Agency.

(4)

Regulation (EC) No 1356/2004 should therefore be amended accordingly.

(5)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Regulation (EC) No 1356/2004 is replaced by the text in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 February 2007.

For the Commission

Markos KYPRIANOU

Member of the Commission

(1)  OJ L 268, 18.10.2003, p. 29. Regulation as amended by Commission Regulation (EC) No 378/2005 (OJ L 59, 5.3.2005, p. 8).

(2)  OJ L 270, 14.12.1970, p. 1. Directive repealed by Regulation (EC) No 1831/2003.

(3)  OJ L 251, 27.7.2004, p. 6.

(4)  Opinion of the Scientific Panel on Additives and Products or Substances used in Animal Feed on the Maximum Residues Limits for monensin sodium for chicken and turkeys for fattening, adopted on 21 November 2006, The EFSA Journal (2006) 413, p. 1-13. See also Opinion of the Scientific Panel on Additives and Products or Substances used in Animal Feed on the request of the Commission on the re-evaluation of coccidiostat Elancoban in accordance with article 9G of Council Directive 70/524/EEC, adopted on 4 March 2004, The EFSA Journal (2004) 42, p. 1-61.

ANNEX

Registration number of additive

Name and registration number of person responsible for putting additive into circulation

Additive

(trade name)

Composition, chemical formula, description

Species or category of animal

Maximum age

Minimum content

Maximum content

Other provisions

End of period of authorisation

Provisional maximum residue limits (MRLs) in the relevant foodstuffs of animal origin

mg of active substance/kg of complete feedingstuff

Coccidiostats and other medicinal substances

‘E 757

Eli Lilly and Company Limited

Monensin sodium (Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200)

 

Active substanc:

C36H61O11Na

sodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis, ATCC 15413 in granular form.

Factor composition:

 

Monensin A: not less than 90 %

 

Monensin: A + B: not less than 95 %

 

Additive composition:

Granular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w

Mineral oil 1-3 % w/w

Limestone granular 13-23 % w/w

Rice hulls or limestone granular qs 100 % w/w

Granular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w

Mineral oil 1-3 % w/w

Rice hulls or limestone granular qs 100 % w/w

Chickens for fattening

—

100

125

Use prohibited at least three days before slaughter. Indicate in the instructions for use:

“Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances”

30.7.2014

25 μg monensin sodium/kg of wet skin + fat.

8 μg monensin sodium/kg of wet liver, kidney and muscle’.

Chickens reared for laying

16 weeks

100

120

Turkeys

16 weeks

60

100
Top